Refurbished ‘green’ Edinburgh Park office building attracts major new tenant

KNIGHT Property Group has secured a major deal at its £20 million ‘green’ office building in Edinburgh Park, with Lumacron Technology having moved its HQ to 4-5 Lochside Avenue.

Lumacron has leased 12,814 sq ft on the ground floor on a 10-year deal and has relocated its staff from Dunfermline into the Grade A office space.

The firm delivers hardware and software solutions for optical communications networks and is described as a ‘trusted partner’ in complex optical infrastructure projects. Founded in 2014, the company also has a North American base in Virginia.

The Edinburgh Park building was originally purchased by Knight in January 2020 and sits on a three-acre site. Rather than demolish the pavilion-style building, Knight redeveloped and refurbished it to provide open-plan office accommodation over three floors.

Alan McDade, president, Lumacron Technology, said, “The standout design and sustainability credentials are a perfect fit and will enable us to have a greater focus on employee health and wellbeing, with natural light and plentiful outdoor space, as well as being in close proximity to a range of public transport options and park amenities.”

Howard Crawshaw, MD of Knight Property Group, added, “We are extremely proud of the building and it is particularly pleasing to have secured an occupier who shares our passion for office buildings that offer superior sustainability and wellness. Further space has been leased and there are other discussions ongoing with potentially interested occupiers to fill the space which is testament to the specification of the building that the team has delivered.”

4-5 Lochside Avenue is an all-electric building, with an EPC ‘B+’ rating.

Angela Lowe, senior director of CBRE, said, “This is a significant letting in one of the strongest buildings in Edinburgh Park and this deal demonstrates the draw of the Edinburgh office market.”

JLL and CBRE are letting agents for Knight Property Group, whilst CuthbertWhite advised Lumacron.